SEK 0.92
(-2.65%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 6.07 Million SEK | -29.45% |
2022 | 8.61 Million SEK | -45.58% |
2021 | 15.82 Million SEK | 852.92% |
2020 | 1.66 Million SEK | -13.35% |
2019 | 1.91 Million SEK | -34.55% |
2018 | 2.92 Million SEK | -52.8% |
2017 | 6.2 Million SEK | 0.0% |
2016 | - SEK | 0.0% |
2015 | - SEK | 0.0% |
2014 | - SEK | 0.0% |
2013 | - SEK | 0.0% |
2012 | - SEK | 0.0% |
2011 | - SEK | 0.0% |
2010 | - SEK | 0.0% |
2009 | - SEK | 0.0% |
2008 | - SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 5.03 Million SEK | -17.18% |
2024 Q2 | 4.8 Million SEK | -4.57% |
2023 Q1 | 9.12 Million SEK | 5.9% |
2023 Q3 | 7.46 Million SEK | 35.88% |
2023 FY | 6.07 Million SEK | -29.45% |
2023 Q4 | 6.07 Million SEK | -18.58% |
2023 Q2 | 5.49 Million SEK | -39.78% |
2022 Q2 | 13.24 Million SEK | -7.91% |
2022 FY | 8.61 Million SEK | -45.58% |
2022 Q4 | 8.61 Million SEK | -27.15% |
2022 Q1 | 14.38 Million SEK | -9.11% |
2022 Q3 | 11.82 Million SEK | -10.75% |
2021 Q3 | 11.01 Million SEK | -6.93% |
2021 FY | 15.82 Million SEK | 852.92% |
2021 Q1 | 396 Thousand SEK | -76.16% |
2021 Q2 | 11.83 Million SEK | 2888.38% |
2021 Q4 | 15.82 Million SEK | 43.71% |
2020 Q3 | 3.6 Million SEK | -38.31% |
2020 Q4 | 1.66 Million SEK | -53.98% |
2020 Q2 | 5.85 Million SEK | -3.42% |
2020 Q1 | 6.05 Million SEK | 216.04% |
2020 FY | 1.66 Million SEK | -13.35% |
2019 Q3 | 3 Million SEK | 404.65% |
2019 FY | 1.91 Million SEK | -34.55% |
2019 Q1 | 2.19 Million SEK | -25.11% |
2019 Q2 | 594.59 Thousand SEK | -72.89% |
2019 Q4 | 1.91 Million SEK | -36.11% |
2018 Q4 | 2.92 Million SEK | -5.28% |
2018 FY | 2.92 Million SEK | -52.8% |
2018 Q3 | 3.09 Million SEK | -33.06% |
2018 Q2 | 4.61 Million SEK | -8.06% |
2018 Q1 | 5.02 Million SEK | -19.03% |
2017 Q3 | 11.42 Million SEK | 128.6% |
2017 Q2 | 5 Million SEK | 0.0% |
2017 Q1 | - SEK | 0.0% |
2017 FY | 6.2 Million SEK | 0.0% |
2017 Q4 | 6.2 Million SEK | -45.71% |
2016 FY | - SEK | 0.0% |
2016 Q3 | - SEK | 0.0% |
2016 Q4 | - SEK | 0.0% |
2016 Q2 | - SEK | 0.0% |
2016 Q1 | - SEK | 0.0% |
2015 Q2 | - SEK | 0.0% |
2015 FY | - SEK | 0.0% |
2015 Q4 | - SEK | 0.0% |
2015 Q3 | - SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2014 Q1 | - SEK | 0.0% |
2014 FY | - SEK | 0.0% |
2014 Q2 | - SEK | 0.0% |
2014 Q4 | - SEK | 0.0% |
2014 Q3 | - SEK | 0.0% |
2013 Q3 | - SEK | 0.0% |
2013 Q2 | - SEK | 0.0% |
2013 FY | - SEK | 0.0% |
2013 Q4 | - SEK | 0.0% |
2013 Q1 | - SEK | 0.0% |
2012 Q3 | - SEK | 0.0% |
2012 Q1 | - SEK | 0.0% |
2012 Q2 | - SEK | 0.0% |
2012 Q4 | - SEK | 0.0% |
2012 FY | - SEK | 0.0% |
2011 Q3 | - SEK | 0.0% |
2011 Q4 | - SEK | 0.0% |
2011 Q2 | - SEK | 0.0% |
2011 FY | - SEK | 0.0% |
2011 Q1 | - SEK | 0.0% |
2010 Q4 | - SEK | -100.0% |
2010 Q3 | 4.5 Million SEK | 28.57% |
2010 FY | - SEK | 0.0% |
2010 Q1 | 3.5 Million SEK | 0.0% |
2010 Q2 | 3.5 Million SEK | 0.0% |
2009 Q3 | 3.5 Million SEK | 0.0% |
2009 FY | - SEK | 0.0% |
2009 Q2 | 3.5 Million SEK | 0.0% |
2009 Q4 | 3.5 Million SEK | 0.0% |
2008 FY | - SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acarix AB (publ) | - SEK | -Infinity% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 99.583% |
ADDvise Group AB (publ) | 1.45 Billion SEK | 99.583% |
Arcoma AB | 1.92 Million SEK | -215.361% |
Bactiguard Holding AB (publ) | 42.3 Million SEK | 85.636% |
BICO Group AB (publ) | 1.75 Billion SEK | 99.654% |
Boule Diagnostics AB (publ) | 57.7 Million SEK | 89.468% |
CellaVision AB (publ) | 28.66 Million SEK | 78.799% |
Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -2625.112% |
Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
C-Rad AB (publ) | 1.75 Million SEK | -246.663% |
Duearity AB (publ) | 2.94 Million SEK | -106.701% |
Episurf Medical AB (publ) | 2.3 Million SEK | -164.217% |
Getinge AB (publ) | 3.9 Billion SEK | 99.844% |
Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | 4.343% |
Iconovo AB (publ) | 4.9 Million SEK | -23.846% |
Integrum AB (publ) | 4.84 Million SEK | -25.44% |
Luxbright AB (publ) | 206.02 Thousand SEK | -2849.656% |
Mentice AB (publ) | 2.14 Million SEK | -183.442% |
OssDsign AB (publ) | 214 Thousand SEK | -2739.72% |
Paxman AB (publ) | 2.53 Million SEK | -140.008% |
Promimic AB (publ) | - SEK | -Infinity% |
Qlife Holding AB (publ) | 3 Million SEK | -102.297% |
SciBase Holding AB (publ) | 4.17 Million SEK | -45.418% |
ScandiDos AB (publ) | - SEK | -Infinity% |
Sectra AB (publ) | 19.2 Million SEK | 68.356% |
Sedana Medical AB (publ) | 1.01 Million SEK | -500.494% |
Senzime AB (publ) | 8.57 Million SEK | 29.156% |
SpectraCure AB (publ) | 4.39 Million SEK | -38.208% |
Stille AB | 38.06 Million SEK | 84.036% |
Vitrolife AB (publ) | 1.87 Billion SEK | 99.676% |
Xvivo Perfusion AB (publ) | 21.16 Million SEK | 71.293% |